Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: IDXX

IDEXX Laboratories, Inc.

Healthcare | Medical - Diagnostics & Research

Market prices for IDXX are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$14.23

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-20 22:10 UTC.

What IDEXX Laboratories, Inc. does

The company operates multiple business segments including CAG (diagnostics and related services), Water, and LPD, which generate revenue from a combination of recurring services, product sales, and software offerings. Revenue is derived from both United States and international markets, with the company reporting growth across all segments during the period. Growth was driven by factors including higher volumes, increased realized prices, new business gains, and expanded product offerings such as diagnostic tests and instruments.

Summarized from IDEXX Laboratories, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$14.23
Return on equity65.99%
Debt/equity0.19

Revenue, margins & earnings

FY2021 Net income: $745MFY2021 Taxes & interest: $187MFY2021 Operating expenses: $957MFY2021 Cost of revenue: $1.33B$3.22BFY2021FY2022 Net income: $679MFY2022 Taxes & interest: $220MFY2022 Operating expenses: $1.11BFY2022 Cost of revenue: $1.36B$3.37BFY2022FY2023 Net income: $845MFY2023 Taxes & interest: $252MFY2023 Operating expenses: $1.09BFY2023 Cost of revenue: $1.47B$3.66BFY2023FY2024 Net income: $888MFY2024 Taxes & interest: $240MFY2024 Operating expenses: $1.25BFY2024 Cost of revenue: $1.52B$3.90BFY2024FY2025 Net income: $1.06BFY2025 Taxes & interest: $301MFY2025 Operating expenses: $1.30BFY2025 Cost of revenue: $1.64B$4.30BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-09
  • 2026-09-09DirectorNon-Qualified Stock Option (right-to-buy)Option exercise-2,203—
  • 2026-09-09DirectorOption exercise2,203$251.5K
  • 2026-09-09DirectorSale-2,203$1.17M
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does IDEXX Laboratories, Inc. do?

The company operates multiple business segments including CAG (diagnostics and related services), Water, and LPD, which generate revenue from a combination of recurring services, product sales, and software offerings.

When did IDXX last file with the SEC?

IDEXX Laboratories, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-15. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 22:10 UTC. This page is also available as JSON at /api/data?ticker=IDXX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for IDXX and 5,000+ tickers.

Create a free account — keep IDXX
For your agent
GET /api/data?ticker=IDXX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt